Florida Cancer Specialists & Research Institute Leverages Real-World Evidence Capabilities To Advance Blood Cancer Treatment
Txylo.com/10286417
Trending...
- Robert Maloy Announces Candidacy for City Council in Windcrest
- Bug Busters Celebrates 40 Years in the Pest Control Industry
- Governor Abbott Touts Texas Crime Stoppers' Success At 35th Annual Conference In Waco
FORT MYERS, Fla., Sept. 6, 2024 ~ At the Society for Hematologic Oncology's 2024 annual meeting in Houston this week, real-world evidence research from Florida Cancer Specialists & Research Institute (FCS) is being presented. FCS President and Managing Physician, Dr. Lucio N. Gordan, spoke about the institute's investments in developing unique datasets that have led to significant insights and improved patient outcomes globally.
Earlier this year, FCS launched a formal effort to collect real-world data from over one million patients and combine it with advanced data science techniques to generate insights that can enhance patient care and aid in the discovery of new therapies. The FCS Real-World Evidence team works with both internal and external partners to provide valuable insights for improving treatment decisions and clinical outcomes based on real-world data.
Dr. Gustavo Fonseca, a medical oncologist and hematologist at FCS, expressed excitement about the institute's contributions to the understanding and treatment of blood cancers and related diseases. He believes that their robust clinical expertise and informatics capabilities make them well-equipped to make significant contributions in this field.
More on Txylo.com
Amanda Warner, FCS director of real-world evidence, will be presenting a poster titled "Perspectives of single-center community hematologists/oncologists on minimal residual disease testing among patients with multiple myeloma." The research was conducted in partnership with Janssen Scientific Affairs, LLC and co-authored by Dr. Gordan, Trevor Heritage (FCS senior vice president and data officer), Amy Ming (FCS senior director of informatics), and Ernest Griffin (FCS manager of data science).
Another poster abstract presentation will feature research results co-authored by Dr. Gordan, Dr. Fonseca, Trevor Heritage, Amanda Warner, Amy Ming, and Ernest Griffin. The study focuses on the management of patients with lower-risk myelodysplastic syndromes in a large US community oncology practice.
The Society for Hematologic Oncology (SOHO) is the only worldwide society dedicated to hematologic malignancies. The 2024 annual meeting will feature presentations from internationally recognized experts on various topics related to leukemias, lymphomas, myeloma, myelodysplastic neoplasms, myeloproliferative neoplasms, and cellular therapy developments.
FCS's participation in this prestigious event highlights their commitment to advancing the understanding and treatment of blood cancers and related diseases. With their extensive informatics capabilities and real-world evidence research, FCS is making significant contributions to improving patient outcomes and enhancing the discovery of new therapies.
Earlier this year, FCS launched a formal effort to collect real-world data from over one million patients and combine it with advanced data science techniques to generate insights that can enhance patient care and aid in the discovery of new therapies. The FCS Real-World Evidence team works with both internal and external partners to provide valuable insights for improving treatment decisions and clinical outcomes based on real-world data.
Dr. Gustavo Fonseca, a medical oncologist and hematologist at FCS, expressed excitement about the institute's contributions to the understanding and treatment of blood cancers and related diseases. He believes that their robust clinical expertise and informatics capabilities make them well-equipped to make significant contributions in this field.
More on Txylo.com
- Bringing Hope and Healing to Amarillo: The Hope & Healing Place Presents "Hope for the Holidays"
- DAISO NEW STORE OPENING IN EL PASO, TEXAS
- Governor Abbott Congratulates Tyler As Third Tourism Friendly Texas Certified Community
- 5 Questions to Ask a Commercial Window Cleaning Company in Los Angeles, CA Before Hiring Them
- Breaking Ground and Forging Partnerships: Recap of Paper Industry's Participation in Drupa Expo and Future Endeavors
Amanda Warner, FCS director of real-world evidence, will be presenting a poster titled "Perspectives of single-center community hematologists/oncologists on minimal residual disease testing among patients with multiple myeloma." The research was conducted in partnership with Janssen Scientific Affairs, LLC and co-authored by Dr. Gordan, Trevor Heritage (FCS senior vice president and data officer), Amy Ming (FCS senior director of informatics), and Ernest Griffin (FCS manager of data science).
Another poster abstract presentation will feature research results co-authored by Dr. Gordan, Dr. Fonseca, Trevor Heritage, Amanda Warner, Amy Ming, and Ernest Griffin. The study focuses on the management of patients with lower-risk myelodysplastic syndromes in a large US community oncology practice.
The Society for Hematologic Oncology (SOHO) is the only worldwide society dedicated to hematologic malignancies. The 2024 annual meeting will feature presentations from internationally recognized experts on various topics related to leukemias, lymphomas, myeloma, myelodysplastic neoplasms, myeloproliferative neoplasms, and cellular therapy developments.
FCS's participation in this prestigious event highlights their commitment to advancing the understanding and treatment of blood cancers and related diseases. With their extensive informatics capabilities and real-world evidence research, FCS is making significant contributions to improving patient outcomes and enhancing the discovery of new therapies.
Filed Under: Business
0 Comments
Latest on Txylo.com
- Texas: Governor Abbott Issues Disaster Declaration, Deploys State Firefighting Resources Amid Growing Wildfire Threat
- Texas: Governor Abbott Issues Wildfire Disaster Proclamation In October 2024
- EnLink Midstream Declares Quarterly Distribution
- Governor Abbott Reappoints Bailey Chair Of Texas Facilities Commission
- Texas: Governor Abbott Recognizes Fentanyl Victims, Raises Awareness In San Antonio
- Governor Abbott Congratulates Abilene As Second Tourism Friendly Texas Certified Community
- Carl Resnick joins Flexible Plan Investments as vice president of national sales
- StrideCare Selected as a Preferred Employer Partner for Remington College
- Project EverGreen Creates A Cooler, Greener Future for New York City's Joe Holzka Community Garden
- Gravesider Mobile App Wants to Hire Actors to Play Dead
- CCHR Wants Increased Consumer Awareness About "Prescriptions for Violence"
- The Giant is Coming to Las Vegas: A Landmark Blending Art, Entertainment & Blockchain for an Unforgettable Experience!
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 6, 2024 in Iris Energy Lawsuit - IREN
- Nurturing Healthy Smiles Through Little Mouth Program
- Experience the Future of Digital Textbook with KITABOO at FBF 2024 and Win an iPad Daily!
- Kingdom Christmas Lights Announces Professional Christmas Light Installation Services for 2024
- Integris Composites Displays New Military Armor at AUSA 2024
- Expert HVAC Upgrade Tips to Maximize Energy Efficiency
- Cynthia Hilston Announces the Release of The Apple of Erin's Eye
- le TonShé to Showcase Luxury Candles and Wax Melts at Black On The Block Dallas